Table 1.
Pre-blood-feeding meal | Number tested | Number infected (%)1 | Number disseminated (%)1 | Number transmitted (%)1 | Body titer2 | Leg titer2 | Saliva titer2 |
---|---|---|---|---|---|---|---|
7 d postinfection | |||||||
DENV | |||||||
Sugar | 10 | 9 (90)a | 3 (30)a | 0 | 4.3±0.4a | 2.5±0.1a | – |
Sugar+bifenthrin | 10 | 8 (80)a | 1 (10)a | 0 | 4.3±0.3a | 2.5a | – |
ZIKV | |||||||
Sugar | 10 | 10 (100)a | 4 (40)b | 1 (10) | 5.1±0.3a | 0.1±0.0a | 1.4 |
Sugar+bifenthrin | 10 | 10 (100)a | 10 (100)a | 0 | 4.2±0.5a | 0.4±0.2a | – |
14 d postinfection | |||||||
DENV | |||||||
Sugar | 10 | 9 (90)a | 2 (20)a | 0 | 5.3±0.2a | 3.7±0.3a | – |
Sugar+bifenthrin | 10 | 4 (40)b | 1 (10)a | 0 | 3.5±1.1b | 2.3a | – |
ZIKV | |||||||
Sugar | 10 | 10 (100)a | 10 (100)a | 0 | 4.9±0.4a | 2.1±0.6a | – |
Sugar+bifenthrin | 5 | 5 (100)a | 5 (100)a | 1 (20) | 5.4±0.2a | 3.3±0.2a | 3.2 |
Notes: Analyses were conducted separately for each virus.
Same letter in the same column for each virus indicates no significant difference between treatments by chi-square test.
Same letter in the same column indicates no significant difference between treatments by means comparison.